New insights on stem cell clones and inflammation in the bones
As humans age, hematopoietic stem cells—the immature precursor cells that give rise to all blood and immune cells—accumulate mutations. Some of the mutations allow these
As humans age, hematopoietic stem cells—the immature precursor cells that give rise to all blood and immune cells—accumulate mutations. Some of the mutations allow these

Envista Holdings Corporation (NYSE: NVST) (※Envista§) and its charitable arm, the Envista Smile Project, announced today that it has partnered with the University of Southern

A company representative from Kuraray Noritake talks to Dr. Joseph Willardsen about his experience using CLEARFIL Universal Bond Quick 2 and MAJESTY ES Flow Universal.
The federally qualified health center will close its dental clinics in Lyons and Mt. Morris, leaving behind clinics in Rushville, Utica and Ilion. The company
Wright Dentures and Implants posted a note on its door in May, stating the office was closed due to “unforeseen circumstances.” The practice’s phone was
Pearl, the global leader in dental AI solutions, and Midwest Dental, one of the leading dental technology and supply distributors in the U.S., today announced

Gingivitis is a prevalent yet often overlooked gum disease that can lead to severe dental issues if not addressed promptly. Understanding what gingivitis entails, its

Each year, millions of children in the United States, including up to half of those with state-funded dental insurance plans, don’t receive the dental treatment

Dental fillings are a fundamental aspect of modern dentistry, playing a crucial role in maintaining oral health and restoring damaged teeth. This comprehensive guide will
PracticeTek has finalized the acquisition of Ora, marking a monumental shift in dental practice management. In collaboration with Total Dental, PracticeTek has taken full ownership
Cancer rates among under-50s in the UK have risen by 24% since 1995, with experts linking the increase to obesity and junk food. This is
Main Content KYOTO: A groundbreaking drug capable of regrowing teeth is set to begin human trials in September 2024, marking a significant advancement in dental